GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

RAMM Pharma RAMM.CN · CAD

Health Care · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.02

0.00%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About RAMM Pharma

Its shares trade on Canadian Securities Exchange under the ticker RAMM.CN. It has been listed since 8 November 2019. In the fiscal year to 31 October 2025, it reported revenue of C$3.4m and a net loss of C$8.9m. At that date it held total assets of C$9.3m and shareholders' equity of C$5.7m.

RAMM Pharma Corp. engages in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-11-08. The firm is engaged in the field of cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals and other cannabis-based products. The firm is also engaged in the field of production, export and commercialization of pet products, food, pharmaceutical specialties, household products and cosmetic products. The firm operates a range of brands, including NettaLife name, including NettaPet, NettaPet Senior, NettaPet Puppies and NettaVet. Its cosmetics portfolio includes Cannabipiel Nite, Cannabipiel Body Lotion, Cannabipiel Hair Conditioner, Cannabipiel Liquid Soap, Cannabipiel Tite, Cannabipiel Cleaning Emulsion, Cannabipiel Shampoo, Cannabipiel Lite and Cannbipiel Facial Tonic. The Company’s subsidiaries include Canapar Corp., Medic Plast SA, Yurelan SA, Glediser SA and RAMM Pharma Holdings Corp.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
8 Nov 2019

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Toronto, Ontario, Canada
  • Engaged in cannabinoid pharmacology and product formulation for cannabis-based pharmaceuticals
  • Operates multiple brands including NettaLife and its associated product lines

Weaknesses

  • Engaged in multiple unrelated product lines including pet products and cosmetics
  • Operates subsidiaries in various countries including Canapar Corp. and Medic Plast SA
  • IPO date is 2019-11-08, indicating a relatively recent market entry

Opportunities

  • Expansion into cannabis-based pharmaceuticals market with growing acceptance
  • Potential to leverage existing brand portfolio for cross-selling in related markets
  • Growth in demand for cannabis-based products across multiple industries

Threats

  • Regulatory challenges in the cannabis industry across different jurisdictions
  • Competition from established pharmaceutical and cosmetic companies
  • Dependence on a single sector (cannabis-based products) for revenue

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.